Skip to main content
SpringerLink
Log in

Ganglioside function in the development and repair of the nervous system

From basic science to clinical application

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Gangliosides play important roles in the normal physiological operations of the nervous system, in particular that of the brain. Changes in ganglioside composition occur in the mammalian brain not only during development, but also in aging and in several neuropathological situations. Gangliosides may modulate the ability of the brain to modify its response to cues or signals from the microenvironment. For example, cultured neurons are known to respond to exogenous ganglioside with changes characteristic of cell differentiation. Gangliosides can amplify the responses of neurons to extrinsic protein factors (neuronotrophic factors) that are normal constituents of the neuron’s environment. The systemic administration of monosialoganglioside also potentiates trophic actions in vivo and improves neural responses following various types of injury to the adult mammalian central nervous system. The possible molecular mechanism(s) underlying the ganglioside effects may reflect an action in modulating ligand-receptor linked transfer of information across the plasma membrane of the cell.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agnati L. F., Fuxe K., Calzà L., Benfenati F., Cavicchioli L., Toffano G., and Goldstein M. (1983) Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.Acta. Physiol. Scand. 119, 347–363.

    PubMed  CAS  Google Scholar 

  • Agnati L. F., Fuxe K., Zini I., Davalli P., Corti A., Calzà L., Toffano G., Zoli M., Piccinini G., and Goldstein M. (1985) Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotrophic activity of gangliosides.Acta Physiol. Scand. 124, 499–506.

    PubMed  CAS  Google Scholar 

  • Ando S. (1983) Gangliosides in the nervous system.Neurochem. Int. 5, 507–537.

    Article  CAS  Google Scholar 

  • Ando S., Tanaka Y., and Kon K. (1986) Membrane aging of the brain synaptosomes with special reference to gangliosides, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Liviana, Padova, pp. 105–112.

    Google Scholar 

  • Argentino C., Sacchetti M. L., Toni D., Savoini G., D’Arcangelo E., Erminio F., Federico F., Ferro Milone F., Gallai V., Gambi D., Mamoli A., Ottonello G., Ponari O., Rebucci G., Senin U., and Fieschi C. (1989) GM1 ganglioside therapy in acute ischemic stroke.Stroke, in press.

  • Barbin G., Manthorpe M., and Varon S. (1984) Purification of the chick eye Ciliary Neuronotrophic Factor.J. Neurochem. 43, 1468–1478.

    Article  PubMed  CAS  Google Scholar 

  • Barde Y.-A., Edgar D., and Thoenen H. (1982) Purification of a new neurotrophic factor from mammalian brain.EMBO J. 1, 549–553.

    PubMed  CAS  Google Scholar 

  • Bassi S., Albizzati M. G., Sbacchi M., Frattola L., and Massarotti M. (1984) Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.J. Neurosci. Res. 12, 493–498.

    Article  PubMed  CAS  Google Scholar 

  • Bassi S., Albizzati M. G., Sbacchi M., Frattola L., and Massarotti M. (1986) Subacute phase of stroke treated with ganglioside GM1, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Liviana, Padova, pp. 461–463.

    Google Scholar 

  • Battistin L., Cesari A., Galligioni F., Marin G., Massarotti M., Paccagnella D., Pellegrini A., and Testa G. (1985) Effects of GM1 ganglioside in cerebrovascular disease. A double-blind trial in 40 cases.Eur. Neurol. 24, 343–351.

    Article  PubMed  CAS  Google Scholar 

  • Baumann N., Harpin M. L., and Jacque C. (1980) Brain gangliosides in the shiverer mutant mouse. Comparison with other dysmyelinated mutants, quaking and jumpy, inNeurological Mutations Affecting Myelination, INSERM Symposium 14, Baumann N., ed., Elsevier-North Holland, Amsterdam, pp. 257–262.

    Google Scholar 

  • Baumann N. A., Harpin M. L., VanEvercooren A. B., Iwamori M., and Maurin Y. (1987) Brain gangliosides and neurological mutants, inGangliosides and Modulation of Neuronal Functions, NATO ASI Series, vol. H7, Rahmann H., ed., Springer-Verlag, Berlin, pp. 391–407.

    Google Scholar 

  • Blackburn C. C., Swank-Hill P., and Schnaar R. L. (1986) Gangliosides support neural retinal cell adhesion.J. Biol. Chem. 261, 2873–2881.

    PubMed  CAS  Google Scholar 

  • Bremer E. G., Schlessinger J., and Hakomori S. (1986) Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.J. Biol. Chem. 261, 2434–2440.

    PubMed  CAS  Google Scholar 

  • Byrne M. C., Farooq M., Sbaschnig-Agler M., Norton W. T., and Ledeen R. W. (1988) Ganglioside content of astroglia and neurons isolated from maturing rat brain.Brain Res. 461, 87–97.

    Article  PubMed  CAS  Google Scholar 

  • Cahn J., Borzeix M. G., and Toffano G. (1986) Effect of GM1 ganglioside and of its inner ester derivative in a model of transient cerebral ischemia in the rat, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Liviana, Padova, pp. 435–443.

    Google Scholar 

  • Calcutt N. A., Tomlinson D. R., and Willars G. B. (1988) Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity.J. Neurochem. 50, 1478–1483.

    Article  PubMed  CAS  Google Scholar 

  • Callies R., Schwarzmann G., Radzak K., Seigert R., and Wiegandt H. (1977) Characterization of the cellular binding of exogenous gangliosides.Eur. J. Biochem. 80, 425–432.

    Article  PubMed  CAS  Google Scholar 

  • Cannella M. S., Roisen F. J., Ogawa T., Sugimoto M., and Ledeen R. W. (1988a) Comparison of epi-GM3 with GM3 and GM1 as stimulators of neurite outgrowth.Dev. Brain Res. 39, 137–143.

    Article  Google Scholar 

  • Cannella M. S., Acher A. J., and Ledeen R. W. (1988b) Stimulation of neurite outgrowth in vitro by a glyceroganglioside.Int. J. Devl. Neurosci. 6, 319–326.

    Article  CAS  Google Scholar 

  • Carpenter D. O., Hall A. F., and Rahmann H. (1988) Exogenous gangliosides induce direct voltage and conductance changes in isolated neurons.Cell. Mol. Neurobiol. 8, 245–250.

    Article  PubMed  CAS  Google Scholar 

  • Casamenti F., Bracco L., Bartolini L., and Pepeu G. (1985) Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei.Brain Res. 338, 45–52.

    Article  PubMed  CAS  Google Scholar 

  • Ceccarelli B., Aporti F., and Finesso M. (1976) Effect of brain gangliosides on functional recovery in experimental regeneration and reinnervation.Adv. Exp. Biol. Med. 71, 275–293.

    CAS  Google Scholar 

  • Chan K.-F. J. (1987a) Ganglioside-modulated protein phosphorylation. Partial purification and characterization of a ganglioside-stimulated protein kinase in brain.J. Biol. Chem. 262, 5248–5255.

    PubMed  CAS  Google Scholar 

  • Chan K.-F. J. (1987b) Ganglioside-modulated protein phosphorylation in myelin.J. Biol. Chem. 262, 2415–2422.

    PubMed  CAS  Google Scholar 

  • Chan K.-F. J. (1988) Ganglioside-modulated protein phosphorylation. Partial purification and characterization of a ganglioside-inhibited protein kinase in brain.J. Biol. Chem. 263, 568–574.

    PubMed  CAS  Google Scholar 

  • Chapman J., Sela B.-A., Wertman E., and Michaelson D. M. (1988) Antibodies to ganglioside GM1 in patients with Alzheimer’s disease.Neurosci. Lett. 86, 235–240.

    Article  PubMed  CAS  Google Scholar 

  • Cheresh D. A., Pierschbacher M. D., Herzig M. A., and Mujoo K. (1986) Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.J. Cell Biol. 102, 688–696.

    Article  PubMed  CAS  Google Scholar 

  • Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system.Neuron 1, 623–634.

    Article  PubMed  CAS  Google Scholar 

  • Chou K. H., Ilyas A. A., Evans J. E., Castello C., Quarles R. H., and Jungalwala F. D. (1986) Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and IgM paraproteins in some neuropathy patients.J. Biol. Chem. 261, 11717–11725.

    PubMed  CAS  Google Scholar 

  • Cimino M., Benfenati F., Farabegoli C., Cattabeni F., Fuxe K., Agnati L. F., and Toffano G. (1987) Differential effect of ganglioside GM1 on rat brain phosphoproteins: potentiation and inhibition of protein phosphorylation regulated by calcium/calmodulin and calcium/phospholipid-dependent protein kinases.Acta Physiol. Scand. 130, 317–325.

    PubMed  CAS  Google Scholar 

  • Collingridge G. L. and Bliss T. V. (1987) NMDA receptors—their role in long-term potentiation.Trends Neurosci. 10, 288–293.

    Article  CAS  Google Scholar 

  • Commissiong J. W. and Toffano G. (1986) The effect of GM1 ganglioside on coerulospinal noradrenergic, adult neurons and on fetal monoaminergic neurons transplanted into the transected spinal cord of the adult rat.Brain Res. 380, 205–215.

    Article  PubMed  CAS  Google Scholar 

  • Coyle J. T. (1982) Excitatory amino acid neurotoxins, inHandbook of Psychopharmacology, vol. 15, Iversen I. L., Iverson S. D. and Snyder S. H., eds., Plenum, NY, pp. 237–269.

    Google Scholar 

  • Cuello A. C., Stephens P. H., Tagari P. C., Sofroniew M. V., and Pearson R. C. A. (1986) Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1.Brain Res. 376, 373–377.

    Article  PubMed  CAS  Google Scholar 

  • Cuello A. C., Garofalo L., Kenigsberg R. L., and Maysinger D. (1989) Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons.Proc. Natl. Acad. Sci. USA 86, 2056–2060.

    Article  PubMed  CAS  Google Scholar 

  • de Laat S. W. and van der Saag P. T. (1982) The plasma membrane as a regulatory site in growth and differentiation of neuroblastoma cells.Int. Rev. Cytol. 74, 1–54.

    Article  PubMed  Google Scholar 

  • de Patre P. L., Casamenti F., Cenni A., and Pepeu G. (1989) Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis.Brain Res. 480, 219–224.

    Article  PubMed  Google Scholar 

  • Doherty P., Dickson J. G., Flanigan T. P., and Walsh F. S. (1985) Ganglioside GM1 does not initiate, but enhances neurite regeneration of nerve growth factor-dependent sensory neurons.J. Neurochem. 44, 1259–1265.

    Article  PubMed  CAS  Google Scholar 

  • Doherty P., Dickson J. G., Flanigan T. P., and Walsh F. S. (1986) Molecular specificity of ganglioside action on neurite regeneration in cell cultures of sensory neurons, inGangliosides and Neuronal Plasticity, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Fidia Research Series, vol. 6, Liviana, Padova, pp. 335–345.

    Google Scholar 

  • Dreyfus H., Louis J. C., Harth S., and Mandel P. (1980) Gangliosides in cultured neurons.Neuroscience 5, 1647–1655.

    Article  PubMed  CAS  Google Scholar 

  • Esmann M., Marsh D., Schwarzmann G., and Sandhoff K. (1988) Ganglioside-protein interactions: spin-label electron spin resonance studies with (Na+−K+)-ATPase membranes.Biochemistry 27, 2398–2403.

    Article  PubMed  CAS  Google Scholar 

  • Facci L., Leon A., Toffano G., Sonnino S., Ghidoni R., and Tettamanti G. (1984) Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1.J. Neurochem. 42, 299–305.

    Article  PubMed  CAS  Google Scholar 

  • Facci L., Skaper S. D., Levin D. L., and Varon S. (1987) Dissociation of the stellate morphology from intracellular cyclic AMP levels in cultured rat brain astroglial cells: effects of ganglioside GM1 and lysophosphatidylserine.J. Neurochem. 48, 566–573.

    Article  PubMed  CAS  Google Scholar 

  • Facci L., Skaper S. D., Favaron M., and Leon A. (1988) A role for gangliosides in astroglial cell differentiation in vitro.J. Cell Biol. 106, 821–828.

    Article  PubMed  CAS  Google Scholar 

  • Facci L., Milani D., Leon A., and Skaper S. D. (1989) Monosialoganglioside protects against anoxic and kainic acid induced neuronal death in vitro.J. Neurochem. 52 (Suppl.), S 183.

    Google Scholar 

  • Fass B., Ramirez J. J., Stein D. G., Mahadik S. P., and Karpiak S. E. (1987) Ganglioside-induced alterations in hippocampal cholinergic enzymes and Na,K-ATPase after fimbria-fornix transection.J. Neurosci. Res. 17, 45–50.

    Article  PubMed  CAS  Google Scholar 

  • Favaron M., Manev H., Alho H., Bertolino M., Ferret B., Guidotti A., and Costa E. (1988) Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex.Proc. Natl. Acad. Sci. USA 85, 7351–7355.

    Article  PubMed  CAS  Google Scholar 

  • Felgner P. L., Thompson T. E., Barenhozz Y., and Lichtenberg D. (1983) Kinetics of transfer of gangliosides from their micelles to dipalmitoylphosphatidylcholine vesicles.Biochemistry 22, 1670–1674.

    Article  PubMed  CAS  Google Scholar 

  • Ferrari G., Fabris M., and Gorio A. (1983) Gangliosides enhance neurite outgrowth in PC12 cells.Dev. Brain Res. 8, 251–221.

    Article  Google Scholar 

  • Fishman P. H. (1982) Role of membrane gangliosides in the binding and action of bacterial toxins.J. Mem. Biol. 69, 85–97.

    Article  CAS  Google Scholar 

  • Fishman P. H., Bradley R. M., Hom B. H., and Moss J. (1983) Uptake and metabolism of exogenous gangliosides by cultured cells: effect of choleragen on the turnover of GM1.J. Lipid Res. 24, 1002–1011.

    PubMed  CAS  Google Scholar 

  • Fusco M., Dona M., Tessari F., Hallman H., Jonsson G., and Gorio A. (1986) GM1 ganglioside counteracts selective neurotoxin-induced lesion of developing serotonin neurons in rat spinal cord.J. Neurosci. Res. 15, 467–479.

    Article  PubMed  CAS  Google Scholar 

  • Fusco M., Figliomeni B., Gorio A., and Vantini G. (1988) Postnatal development of bulbospinal serotonergic system. Effects of GM1 ganglioside following neonatal 5,7-dihydroxytryptamine treatment.Neurochem. Int. 13, 251–259.

    Article  CAS  Google Scholar 

  • Gallo V., Ciotti M. T., Coletti A., Aloisi F., and Levi G. (1982) Selective release of glutamate from cerebellar granule cells differentiating in culture.Proc. Natl. Acad. Sci. USA 79, 7919–7923.

    Article  PubMed  CAS  Google Scholar 

  • Gasser U. E., Weskamp G., Otten U., and Dravid A. R. (1986) Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septo-hippocampal pathway in rats.Brain Res. 376, 351–356.

    Article  PubMed  CAS  Google Scholar 

  • Ghidoni R., Trinchera M., Venerando B., Fiorilli A., and Tettamanti G. (1986) Metabolism of exogenous GM1 and related glycolipids in the rat, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tetamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Liviana Press, Padova, pp. 183–200.

    Google Scholar 

  • Goldenring J. R., Otis L. C., Yu R. K., and De Lorenzo R. J. (1985) Calcium/ganglioside-dependent protein kinase activity in rat brain membrane.J. Neurochem. 44, 1229–1234.

    Article  PubMed  CAS  Google Scholar 

  • Goldman J. E., Hirano M., Yu R. K., and Seyfied T. N. (1984) GD3 ganglioside is a glycolipid characteristic of immature neuroectodermal cells.J. Neurochem. 7, 179–192.

    CAS  Google Scholar 

  • Gorio A., Carmignoto G., Facci L., and Finesso M. (1980) Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth.Brain Res. 197, 236–241.

    Article  PubMed  CAS  Google Scholar 

  • Gorio A., Marini P., and Zanoni R. (1983) Muscle reinnervation. III. Motoneurons sprouting capacity, enhancement by exogenous gangliosides.Neuroscience 8, 417–429.

    Article  PubMed  CAS  Google Scholar 

  • Gradkowska M., Skup M., Kiedrowski L., Calzolari S., and Oderfeld-Nowak B. (1986) The effect of GM1 ganglioside on cholinergic and serotoninergic systems in the rat hippocampus following partial denervation is dependent on the degree of fiber regeneration.Brain Res. 375, 417–422.

    Article  PubMed  CAS  Google Scholar 

  • Greene L. A. and Shooter E. M. (1980) The nerve growth factor: biochemistry, synthesis and mechanism of action.Ann Rev. Neurosci. 3, 353–402.

    Article  PubMed  CAS  Google Scholar 

  • Hadjiconstantinou M. and Neff N. H. (1986) Treatment with GM1 ganglioside increases rat spinal cord indole content.Brain Res. 366, 343–345.

    Article  PubMed  CAS  Google Scholar 

  • Hadjiconstantinou M., Rosetti Z. L., Paxton R. C., and Neff N. H. (1986) Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP.Neuropharmacology 25, 1075–1077.

    Article  PubMed  CAS  Google Scholar 

  • Hanai N., Dohi T., Nores G. A., and Hakomori S. (1988a) A novel ganglioside, de-N-acetyl-GM3 (II3 NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth.J. Biol. Chem. 263, 6296–6301.

    PubMed  CAS  Google Scholar 

  • Hanai N., Nores G. A., MacLeod C., Torres-Mendez C.-R., and Hakomori S. (1988b) Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor.J. Biol. Chem. 263, 10915–10921.

    PubMed  CAS  Google Scholar 

  • Hefti F. (1986) Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transection.J. Neurosci. 6, 2155–2162.

    PubMed  CAS  Google Scholar 

  • Heikkila R. E., Hess A., and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.Science 224, 1451–1453.

    Article  PubMed  CAS  Google Scholar 

  • Hilbig R., Lauke G., and Rahmann H. (1983/84) Brain gangliosides during the lifespan (embryogenesis to senescence) of the rat.Dev Neurosci. 6, 260–270.

    Article  PubMed  Google Scholar 

  • Hilbush B. S. and Levine J. M. (1988) Ganglioside GM1 modulation of protein kinase activity in PC12 cells,Soc. Neurosci. Abst. 14, 768.

    Google Scholar 

  • Hinrichs U., Sonderfeld S., Schwarzmann G., Conzelmann E., and Sandhoff K. (1986) Concepts of ganglioside metabolism, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Liviana, Padova, pp. 172–182.

    Google Scholar 

  • Hörmann M. (1988) Efficacy and safety of ganglioside GM1 treatment in the rehabilitation of patients following closed traumatic head injury. Results of an interim evaluation, inNew Trends in Ganglioside Research: Neurochemical and Neuroregenerative Aspects, Fidia Research Series, vol. 14, Ledeen R. W., Hogan E. L., Tettamanti G., Yates A. J., and Yu R. K., eds., Liviana, Padova, pp. 595–604.

    Google Scholar 

  • Ilyas A. A., Quarles R. H., MacIntosh T. D., Dobersen M. J., Trapp B. D., Dalakas M. C., and Brady R. O. (1984) IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glyco-protein and to a ganglioside.Proc. Natl. Acad. Sci. USA 81, 1225–1229.

    Article  PubMed  CAS  Google Scholar 

  • Ilyas A. A., Quarles R. H., Dalakas M. C., Fishman P. H., and Brady R. O. (1985) Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups.Ann. Neurol. 18, 655–659.

    Article  PubMed  CAS  Google Scholar 

  • Ilyas A. A., Willison H. J., Quarles R. H., Jungalwala F. B., Cornblath D. R., Trapp B. D., Griffin D. E., Griffin J. W., and McKhann G. M. (1988a) Serum antibodies to gangliosides in Guillain-Barré syndrome.Ann. Neurol. 23, 440–447.

    Article  PubMed  CAS  Google Scholar 

  • Ilyas A. A., Willison H. J., Delakas M. C., Whitaker J. N., and Quarles R. H. (1988b) Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy.J. Neurochem. 51, 851–858.

    Article  PubMed  CAS  Google Scholar 

  • Ilyas A. A., Li S.-C., Chou D. K. H., Li, Y.-H., Jungalwala F. B., Dalakas M. C., and Quarles R. H. (1988c) Gangliosides GM2, IV4Ga1NAcGM1b, and IV4Ga1NAcGD1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy.J. Biol. Chem. 263, 4369–4373.

    PubMed  CAS  Google Scholar 

  • Johnson W. (1981) The clinical spectrum of hexosaminidase deficiency diseases.Neurology 31, 1453–1456.

    PubMed  CAS  Google Scholar 

  • Jonsson, G., Gorio A., Hallman H., Janigro D., Kojima H., Luthman J., and Zanoni R. (1984) Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins.J. Neurosci. Res. 12, 459–475.

    Article  PubMed  CAS  Google Scholar 

  • Jope R. S., Baker H. J., and Connor D. J. (1985) Increased acetylcholine synthesis and release in brains of cats with GM1-gangliosidosis.J. Neurochem. 46, 1567–1572.

    Article  Google Scholar 

  • Kalia M. and Di Palma J. R. (1982) Ganglioside-induced acceleration of axonal transport following nerve crush injury in the cat.Neurosci. Lett. 34, 1–5.

    Article  PubMed  CAS  Google Scholar 

  • Karpiak S. E. (1983) Ganglioside treatment improves recovery of alteration behavior after unilateral entorhinal cortex lesion.Exp. Neurol. 81, 330–339.

    Article  PubMed  CAS  Google Scholar 

  • Karpiak S. E., Graf L., and Rapport M. M. (1976) Antiserum to brain gangliosides produces recurrent epileptiform activity.Science 194, 735–737.

    Article  PubMed  CAS  Google Scholar 

  • Karpiak S. E., Li Y. S., and Mahadik S. P. (1987) Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function.Stroke 18, 184–187.

    PubMed  CAS  Google Scholar 

  • Karpiak S. E., Li Y. S., and Mahadik S. P. (1988) Ischemic injury reduced by GM1 ganglioside, inNew Trends in Ganglioside Research: Neurochemical and Neuroregenerative Aspects, Fidia Research Series, vol. 14, Ledeen R. W., Hogan E. L., Tettamanti G., Yates A. J., and Yu R. K., eds., Liviana, Padova, pp. 549–556.

    Google Scholar 

  • Kasarskis E. J., Karpiak S. E., Rapport M. M., Yu R. K., and Bass N. H. (1981) Abnormal maturation of cerebral cortex and behavioral deficit in adult rats after neonatal administration of antibodies to gangliosides.Dev. Brain Res. 1, 25–35.

    Article  CAS  Google Scholar 

  • Katoh-Semba R., Skaper S. D., and Varon S. (1984) Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum-and NGF-dependent effects on neuritic growth (and proliferation).J. Neurosci. Res. 12, 299–310.

    Article  PubMed  CAS  Google Scholar 

  • Kellie S., Patel B., Pierce E. J., and Critchley D. R. (1983) Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of α-actinin.J. Cell Biol. 97, 447–454.

    Article  PubMed  CAS  Google Scholar 

  • Kim S. U., Moretto G., and Yu R. K. (1986) Neuroimmunology of gangliosides in human neurons and glial cells in culture.J. Neurochem. Res. 15, 303–321.

    CAS  Google Scholar 

  • Kleinebeckel D. (1982) Acceleration of muscle reinnervation in rats by ganglioside treatment: an electromyographic study.Eur. J. Pharmacol. 80, 243–245.

    Article  PubMed  CAS  Google Scholar 

  • Klenk E. (1942) Ueber di Ganglioside, eine neue Gruppe von Zucherhaltingen Gehirnlipiden.Hoppe-Seyler’s Z. physiol. Chem. 273, 76–86.

    CAS  Google Scholar 

  • Kojima H., Gorio A., Janigro D., and Jonsson G. (1984) GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine.Neuroscience 13, 1011–1022.

    Article  PubMed  CAS  Google Scholar 

  • Komatsumoto S., Greenberg J. H., Hickey W. F., and Reivich M. (1988) Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats.Stroke 19, 1027–1035.

    PubMed  CAS  Google Scholar 

  • Korsching S. (1986) The role of nerve growth factor in the CNS.Trends Neurosci. 9, 570–573.

    Article  CAS  Google Scholar 

  • Kracun I., Rösner H., and Cosovic C. (1986) Topographical distribution of the gangliosides in the developing and adult human brain, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tettamanti G., Ledeen R. W., Sandkoff K., Nagai Y., and Toffano G., eds., Liviana, Padova, pp. 67–76.

    Google Scholar 

  • Kreutter D., Kim J. Y. H., Goldenring J. R., Rasmussen H., Ukomadu C., De Lorenzo R. J., and Yu R. K. (1987) Regulation of protein kinase C activity by gangliosides.J. Biol. Chem. 262, 1633–1637.

    PubMed  CAS  Google Scholar 

  • Kromer L. F. (1987) Nerve growth factor treatment after brain injury prevents neuronal death.Science 235, 214–216.

    Article  PubMed  CAS  Google Scholar 

  • Ledeen R. W. (1983) Gangliosides, inHandbook of Neurochemistry, vol. 3, Lajtha A., ed., Plenum, NY, pp. 41–90.

    Google Scholar 

  • Ledeen R. W. (1985) Gangliosides of the neuron.Trends Neurosci. 8, 169–174.

    Article  CAS  Google Scholar 

  • Leon A., Facci L., Toffano G., Sonnino S., and Tettamanti G. (1981) Activation of (Na+, K+) ATPase by nanomolar concentrations of GM1 ganglioside.J. Neurochem. 37, 350–357.

    Article  PubMed  CAS  Google Scholar 

  • Leon A., Facci L., Benvegnù D., and Toffano G. (1982) Morphological and biochemical effects of gangliosides in neuroblastoma cells.Dev. Neurosci. 5, 108–114.

    Article  PubMed  CAS  Google Scholar 

  • Leon A., Benvegnù D., Dal Toso R., Presti D., Facci L., Giorgi O., and Toffano G. (1984) Dorsal root ganglia and nerve growth factor: a model for understanding the mechanism of GM1 effects on neuronal repair.J. Neurosci. Res. 12, 277–287.

    Article  PubMed  CAS  Google Scholar 

  • Leon A., Dal Toso R., Presti D., Benvegnù D., Facci L., Kirschner G., Tettamanti G., and Toffano G. (1988) Development and survival of neurons in dissociated fetal mesencephalicserum-free cell cultures: II. Modulatory effects of gangliosides.J. Neurosci. 8, 746–753.

    PubMed  CAS  Google Scholar 

  • Levi-Montalcini R. (1966) Nerve growth factor: its mode of action on sensory and sympathetic neurons.Harvey Lect. 60 217–259.

    PubMed  CAS  Google Scholar 

  • Levi-Montalcini R. (1987) The nerve growth factor thirty five years later.Science 237, 1154–1162.

    Article  PubMed  CAS  Google Scholar 

  • Li Y. S., Mahadik S. P., Rapport M. M., and Karpiak S. E. (1986) Acute effects of GM1 ganglioside: Reduction in both behavioral asymmetry and loss of Na+, K+-ATPase after nigrostriatal transection.Brain Res. 377, 292–297.

    Article  PubMed  CAS  Google Scholar 

  • Maggio B. (1985) Geometric and thermodynamic restrictions for self-assembly of glycosphingolipid-phospholipid systems.Biochim. Biophys. Acta. 815, 245–258.

    Article  PubMed  CAS  Google Scholar 

  • Mahadik S. P. and Karpiak S. K. (1988) Gangliosides in treatment of neural injury and disease.Drug Devl. Res. 15, 337–360.

    Article  CAS  Google Scholar 

  • Mahadik S. P., Vilim F., Korenovsky A., and Karpiak S. E. (1988) GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality.J. Neurosci. Res. 20, 479–483.

    Article  PubMed  CAS  Google Scholar 

  • Manthorpe M., Skaper S. D., Williams L. R., and Varon S. (1986) Purification of adult rat sciatic nerve ciliary neuronotrophic factor.Brain Res. 367, 282–286.

    Article  PubMed  CAS  Google Scholar 

  • Marini P., Vitadello M., Bianchi R., Triban C., and Gorio A. (1986) Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxandiabetic rats: effect of ganglioside treatment.Diabetologia 29, 254–258.

    Article  PubMed  CAS  Google Scholar 

  • Massarelli R., Ferret B., Gorio A., Durand M., and Dreyfus H. (1985) The effect of exogenous gangliosides on neurons in culture: a morphometric analysis.Int. J. Dev. Neurosci. 3, 341–348.

    Article  CAS  Google Scholar 

  • Massarotti M. (1986) Ganglioside therapy of peripheral neuropathies: a review of clinical literature, inGangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Liviana, Padova, pp. 465–479.

    Google Scholar 

  • McIlwain H. (1963) Chemical exploration of the brain: A study of cerebral excitability and ion movement, Elsevier, Amsterdam.

    Google Scholar 

  • Morgan J. I., and Seifert W. (1979) Growth factors and gangliosides: a possible new perspective in neuronal growth control.J. Supramol. Struct. 10, 111–124.

    Article  PubMed  CAS  Google Scholar 

  • Moss J., Fishman P. H., Manganiello V. C., Vaughan M., and Brady R. O. (1976) Functional incorporation of gangliosides into intact cells: induction of choleragen responsiveness.Proc. Natl. Acad. Sci. USA 73, 1034–1037.

    Article  PubMed  CAS  Google Scholar 

  • Nardelli E., Steck A. J., Barkas T., Schleup M., and Jerusalem F. (1988) Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.Ann. Neurol. 23, 524–528.

    Article  PubMed  CAS  Google Scholar 

  • Nieto-Sampedro M., Manthorpe M., Barbin G., Varon S., and Cotman C. W. (1983) Injury-induced neuronotrophic activity in adult rat brain. Correlation with survival of delayed implants in a wound cavity.J. Neurosci. 3, 2219–2229.

    PubMed  CAS  Google Scholar 

  • Norido F., Canella R., and Aporti F. (1981) Acceleration of nerve regeneration by gangliosides estimated by somatosensory evoked potentials (SEP).Experientia 37, 301,302.

    Article  PubMed  CAS  Google Scholar 

  • Norido F., Canella R., Zanoni R., and Gorio A. (1984) The development of diabetic neuropathy in the C57 BL/Ks (db/db) mouse and its treatment with gangliosides.Exp. Neurol. 83, 221–232.

    PubMed  CAS  Google Scholar 

  • O’Brien J. S. (1983) Gangliosides, inThe Metabolic Basis of Inherited Disease, Stanbury J. B., Wyngaarden J. B., Fredrickson D. S., Goldstein J. L., and Brown M. S., eds., McGraw-Hill, NY, pp. 945–969.

    Google Scholar 

  • Oderfeld-Nowak B., Skup M., Ulas J., Jezierska M., Gradkowska M., and Zaremba M. (1984) Effect of ganglioside GM1 treatment on post-lesion responses of cholinergic enzymes in rat hippocampus after various partial deafferentiations.J. Neurosci. Res. 12, 409–420.

    Article  PubMed  CAS  Google Scholar 

  • Poplawsky A. (1987) The GM1 ganglioside hastens the reduction of hyperemotionality after septal lesions.Behavioral and Neural Biology 48, 150–158.

    Article  PubMed  CAS  Google Scholar 

  • Purpura D. (1978) Ectopic dendritic growth in mature pyramidal neurons in human ganglioside storage disease.Nature 276, 520, 521.

    Article  PubMed  CAS  Google Scholar 

  • Purpura D. P. and Suzuki K. (1976) Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage diseases.Brain Res. 116, 1–21.

    Article  PubMed  CAS  Google Scholar 

  • Purpura D. P. and Baker H. J. (1977) Neurite induction in mature cortical neurons in feline GM1-ganglioside storage disease.Nature 266, 553, 554.

    Article  PubMed  CAS  Google Scholar 

  • Purpura D. P. and Baker H. J. (1978) Mmeganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: a Golgi study.Brain Res. 143, 13–26.

    Article  PubMed  CAS  Google Scholar 

  • Quarles R. H., Ilyas A. A., and Willison H. J. (1986) Antibodies to glycolipids in demyelinating disease of the human peripheral nervous system.Chem. Phys. Lipids 42, 235–248.

    Article  PubMed  CAS  Google Scholar 

  • Quinn N. P., Rossor M. N., and Marsden C. D. (1986) Dementia and Parkinson’s disease—pathological and neurochemical considerations.Br. Med. Bull. 42, 86–90.

    PubMed  CAS  Google Scholar 

  • Radzak K., Schwarzmann G., and Wiegandt H. (1982) Studies on the cell association of exogenously added sialoglycolipids. Hoppe Seylers Z.Physiol. Chem. 263, 243–272.

    Google Scholar 

  • Raiteri M., Versace P., Maura P., and Marchi M. (1988) Parenteral treatment with GM1 monosialoganglioside induces recovery of dopamine synthesis and release following nigrostriatal hemitransection.Neurosci. Res. Commun. 3, 69–75.

    CAS  Google Scholar 

  • Revesz T. and Greaves M. (1975) Ligand-induced distribution of lymphocyte membrane ganglioside GM1.Nature 257, 103–106.

    Article  PubMed  CAS  Google Scholar 

  • Robb G. A. and Keynes R. J. (1984) Stimulation of nodal and terminal sprouting of mouse motor nerves by gangliosides.Brain Res. 295, 368–371.

    Article  PubMed  CAS  Google Scholar 

  • Roisen F. J., Bartfeld H., Nagele R., and Yorke G. (1981) Ganglioside stimulation of axonal sprouting in vitro.Science 214, 577, 578.

    Article  PubMed  CAS  Google Scholar 

  • Roisen F. J., Matta S. G., Yorke G., and Rapport M. M. (1986) The role of gangliosides in neurotrophic interaction in vitro, inGangliosides and Neuronal Plasticity, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Fidia Research Series, vol. 6, Liviana, Padova, pp. 283–293.

    Google Scholar 

  • Rösner H. (1977) Gangliosides, sialoglycoproteins and acetylcholinesterase of the developing mouse brain.Roux’s Arch. Dev. Biol. 183, 325–335.

    Google Scholar 

  • Rösner H. (1980) Ganglioside changes in the chicken optic lobes and cerebrum during embryonic development. Transient occurrence of “novel” multisialogangliosides.Roux’s Arch. Dev. Biol. 188, 205–213.

    Google Scholar 

  • Rösner H. (1982) Ganglioside changes in the chicken optic lobes as biochemical indicators of brain development and maturation.Brain Res. 236, 49–61.

    Article  PubMed  Google Scholar 

  • Rösner H. and Rahmann H. (1987) Ontogeny of vertebrate brain gangliosides, inGangliosides and Modulation of Neuronal Functions, NATO ASI Series, vol. H7, Rahmann H., ed., Springer-Verlag, Berlin, pp. 373–390.

    Google Scholar 

  • Rothman S. M. and Olney J. W. (1986) Glutamate and the pathophysiology of hypoxic-schemic brain damage.Ann. Neurol. 19, 105–111.

    Article  PubMed  CAS  Google Scholar 

  • Rothman S. M. and Olney J. W. (1987) Excitotoxicity and the NMDA receptor.Trends Neurosci. 10, 299–302.

    Article  CAS  Google Scholar 

  • Rybak S., Ginsburg I., and Yavin E. (1983) Gangliosides stimulate neurite outgrowth and induce tubulin mRNA accumulation in neural cells.Biochem. Biophys. Res. Comm. 116, 974–980.

    Article  PubMed  CAS  Google Scholar 

  • Sabel B. A., Slavin M. D., and Stein D. G. (1984) GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage.Science 225, 340–342.

    Article  PubMed  CAS  Google Scholar 

  • Sandhoff K. and Christomou H. (1979) Biochemistry and genetics of gangliosidoses.Human Genetics 50, 107–143.

    Article  PubMed  CAS  Google Scholar 

  • Sbaschnig-Agler M., Dreyfus H., Norton W. T., Sensenbrenner M., Farooq M., Byrne M. C., and Ledeen R. W. (1988) Gangliosides of cultured astroglia.Brain Res. 461, 98–106.

    Article  PubMed  CAS  Google Scholar 

  • Schwartz M. and Spirman N. (1982) Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies.Proc. Natl. Acad. Sci. USA 79 6080–6083.

    Article  PubMed  CAS  Google Scholar 

  • Schwarzmann G., Hoffmann-Bleihauer P., Shubert J., Sandhoff K., and Marsh D. (1983) Incorporation of ganglioside analogues into fibroblast cell membranes. A spin label study.Biochemistry 22, 5041–5048.

    Article  PubMed  CAS  Google Scholar 

  • Selak I., Skaper S. D., and Varon S. (1985) Pyruvate participation in the low molecular weight trophic activity for CNS neurons in glia-conditioned media.J. Neurosci. 5, 23–28.

    PubMed  CAS  Google Scholar 

  • Seren M. S., Lazzaro A., Rubini R., Zanoni R., Skaper S. D., and Leon A. (1989) Cerebral ischemia and excitatory amino acid transmitter-induced neurodegeneration: effects of monosialoganglioside treatment, inPharmacology of Cerebral Ischemia 1988, Krieglstein J., ed., CRC Press, Boca Raton, pp. 285–288.

    Google Scholar 

  • Seybold U. and Rahmann H. (1985) Brain gangliosides in birds with different types of postnatal development.Dev. Brain Res. 17, 201–208.

    Article  CAS  Google Scholar 

  • Seyfried T. N., Yu R. K., and Miyazawa N. (1982) Differential cellular enrichment of gangliosides in the mouse cerebellum: analysis using neurological mutants.J. Neurochem. 38, 551–559.

    Article  PubMed  CAS  Google Scholar 

  • Sharon F. J. and Grant C. W. M. (1978) A model for ganglioside behaviors in cell membranes.Biochim. Biophys. Acta. 507, 280–293.

    Article  Google Scholar 

  • Skaper S. D. and Varon S. (1985) Ganglioside GM1 overcomes serum inhibition of neuritic outgrowth.Int. J. Dev. Neurosci. 3, 187–198.

    Article  CAS  Google Scholar 

  • Skaper S. D., Katoh-Semba R., and Varon S. (1985) GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions.Dev. Brain Res. 23, 19–26.

    Article  CAS  Google Scholar 

  • Skaper S. D., Facci L., Rudge J., Katoh-Semba R., Manthorpe M., and Varon S. (1986) Morphological modulation of cultured rat brain astroglial cells: antagonism by ganglioside GM1.Dev. Brain Res. 25, 21–31.

    Article  CAS  Google Scholar 

  • Skaper S. D., Facci L., Favaron M., and Leon A. (1988) Inhibition of DNA synthesis in C6 glioma cells following incorporation of GM1 ganglioside and choleragenoid exposure.J. Neurochem. 51, 688–697.

    Article  PubMed  CAS  Google Scholar 

  • Sofroniew M. V., Pearson R. C. A., Cuello A. C., Tagari P. C., and Stephens P. H. (1986) Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrain.Brain Res. 398, 393–396.

    Article  PubMed  CAS  Google Scholar 

  • Sparrow J. R. and Grafstein B. (1982) Sciatic nerve regeneration in ganglioside-treated rats.Exp. Neurol. 77, 230–235.

    Article  PubMed  CAS  Google Scholar 

  • Sparrow J. R., McGuiness C., Schwartz M., and Grafstein B. (1984) Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo.J. Neurosci. Res. 12, 233–243.

    Article  PubMed  CAS  Google Scholar 

  • Spiegel S. and Fishman P. H. (1987) Gangliosides as bimodal regulators of cell growth.Proc. Natl. Acad. Sci. USA 84, 141–145.

    Article  PubMed  CAS  Google Scholar 

  • Spiegel S., Kassis S., Wilchek M., and Fishman P. H. (1984) Direct visualization of redistribution and capping of fluorescent gangliosides on lymphocytes.J. Cell Biol. 99, 1575–1581.

    Article  PubMed  CAS  Google Scholar 

  • Spirman N., Sela B. A., and Schwartz M. (1982) Antiganglioside antibodies inhibit neuritic outgrowth from regenerating goldfish retinal explants.J. Neurochem. 39, 874–877.

    Article  PubMed  CAS  Google Scholar 

  • Spoerri P. E. (1986) Facilitated-establishment of contacts and synapses in neuronal cultures: ganglioside-mediated neurite sprouting and outgrowth, inGangliosides and Neuronal Plasticity, Tettamanti G., Ledeen R. W., Sandhoff K., Nagai Y., and Toffano G., eds., Fidia Research Series, vol. 6, Liviana, Padova, pp. 309–325.

    Google Scholar 

  • Spoerri P. E. and Roisen F. J. (1988) Ganglioside potentiation of NGF-independent trophic agents on sensory ganglia.Neurosci. Lett. 90, 21–26.

    Article  PubMed  CAS  Google Scholar 

  • Spoerri P. E., Rapport M. M., Mahadik S. P., and Roisen F. J. (1988) Inhibition of conditioned mediamediated neuritogenesis of sensory ganglia by monoclonal antibodies to GM1 ganglioside.Dev. Brain Res. 41, 71–77.

    Article  Google Scholar 

  • Stein G. and Sabel B. (1988) Pharmacological approaches to the treatment of brain and spinal cord injury. Plenum, NY, pp. 1–385.

    Google Scholar 

  • Stephens P. H., Tagari P. C., and Cuello A. C. (1988) Retrograde degeneration of basal forebrain cholinergic neurons after neurotoxic lesions of the neocortex: application of ganglioside GM1.Neurochem. Int. 12, 475–481.

    Article  CAS  Google Scholar 

  • Svennerholm L. (1963) Chromatographic separation of human brain gangliosides.J. Neurochem. 10, 613–623.

    Article  PubMed  CAS  Google Scholar 

  • Svennerholm L. (1984) Biological significance of gangliosides, inCellular and Pathological Aspects of Glycoconjugate Metabolism, vol. 126, Dreyfus H., Massarelli R., Freysz L., and Rebel G., eds., INSERM, Paris, pp. 21–44.

    Google Scholar 

  • Tanaka K., Dora E., Urbanics R., Greenberg J. H., Toffano G., and Reivich M. (1986) Effects of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats.Stroke 17, 1170–1178.

    PubMed  CAS  Google Scholar 

  • Tettamanti G., Sonnino S., Ghidoni R., Masserini M., and Venerando B. (1985) Chemical and functional properties of gangliosides. Their possible implication in the membrane-mediated transfer of information, inPhysics of Amphiphiles: Micelles, Vesicles, and Microemulsions, de Giorgio V. and Corti M., eds., XC Corso Società Italiana di Fisica, Bologna, pp. 607–636.

    Google Scholar 

  • Tettamanti G., Ghidoni R., and Trinchera M. (1987) Fundamentals of brain ganglioside biosynthesis, inGangliosides and Modulation of Neuronal Functions, NATO ASI Series, vol. H7, Rahmann H., ed., Springer-Verlag, Berlin, pp. 191–204.

    Google Scholar 

  • Thompson L. K., Horowitz P. M., Bentley K. L., Thomas D. D., Alderete J. F., and Klebe R. J. (1986) Localization of the ganglioside-binding site of fibronectin.J. Biol. Chem. 261, 5209–5214.

    PubMed  CAS  Google Scholar 

  • Toffano G., Savoini G., Moroni F., Lombardi G., Calzà L., and Agnati L. F. (1983) GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.Brain Res. 261, 163–166.

    Article  PubMed  CAS  Google Scholar 

  • Toffano G., Agnati L. F., Fuxe K., Aldinio C., Consolazione A., Valenti G., and Savoini G. (1984a) Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.Acta Physiol. Scand. 122, 313–321.

    Article  PubMed  CAS  Google Scholar 

  • Toffano G., Savoini G., Moroni F., Lombardi G., Calzà L., and Agnati F. (1984b) Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in the rat.Brain Res. 296, 233–239.

    Article  PubMed  CAS  Google Scholar 

  • Tsuji S., Arita M., and Nagai Y. (1983) GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines.J. Biochem. 94, 303–306.

    PubMed  CAS  Google Scholar 

  • Tsuji S., Nakajima J., Sasaki T., and Nagai Y. (1985) Bioactive gangliosides. IV. Ganglioside GQ1b/ Ca2+-dependent protein kinase activity exists in the plasma membrane fraction of neuroblastoma cell line, GOTO.J. Biochem. 97, 969–972.

    PubMed  CAS  Google Scholar 

  • Vaccarino F., Guidotti A., and Costa E. (1987) Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons.Proc. Natl. Acad. Sci. USA 84, 8707–8711.

    Article  PubMed  CAS  Google Scholar 

  • Vanier M. T., Holm M., Oehmann R., and Svennerholm L. (1971) Developmental profiles of gangliosides in human and rat brain.J. Neurochem. 18, 581–592.

    Article  PubMed  CAS  Google Scholar 

  • Vantini G., Fusco M., Bigon E., and Leon A. (1988) GM1 ganglioside potentiates the effect of nerve growth factor in preventing vinblastine-induced sympathectomy in newborn rats.Brain Res. 448, 252–258.

    Article  PubMed  CAS  Google Scholar 

  • Vyskocil F., Di Gregorio F., and Gorio A. (1985) The facilitating effect of gangliosides on the electrogenic (Na+/K+) pump and on the resistance of the membrane potential to hypoxia in neuromuscular prep arations.Pflügers Arch. 403, 1–6.

    Article  PubMed  CAS  Google Scholar 

  • Watters D. J. and Hendry I. A. (1987) Purification of a ciliary neurotrophic factor from bovine heart.J. Neurochem. 49, 705–713.

    Article  PubMed  CAS  Google Scholar 

  • Weihmuller F. B., Hadjiconstantinou M., Bruno J. P., and Neff N. H. (1988) Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice.Neurosci. Lett. 92, 207–212.

    Article  PubMed  CAS  Google Scholar 

  • Wiegandt H. (1982) The gangliosides.Adv. Neurochem. 4, 149–223.

    Article  CAS  Google Scholar 

  • Williams L. R., Varon S., Peterson G. M., Wictorin K., Fischer W., Björklund A., and Gage F. H. (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.Proc. Natl. Acad. Sci. USA 83, 9231–9235.

    Article  PubMed  CAS  Google Scholar 

  • Willinger M. and Schachner M. (1980) GM1 ganglioside as a marker for neuronal differentiation in mouse cerebellum.Dev. Biol. 74, 101–117.

    Article  PubMed  CAS  Google Scholar 

  • Yavin E. Gil S., Consolazione A., Dal Toso R., and Leon A. (1987) Selective enhancement of tubulin gene expression and increase in oligo (dT)-bound RNA in rat brain after nigrostriatal pathway unilateral lesion and treatment with ganglioside.J. Neurosci. Res. 18, 615–620.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of CNS Research, Fidia Research Laboratories, Via Ponte della Fabbrica 3/A, 35031, Abano Terme, Italy

    Stephen D. Skaper, Alberta Leon & Gino Toffano

Authors
  1. Stephen D. Skaper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberta Leon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gino Toffano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skaper, S.D., Leon, A. & Toffano, G. Ganglioside function in the development and repair of the nervous system. Mol Neurobiol 3, 173–199 (1989). https://doi.org/10.1007/BF02935630

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02935630

Index Entries

Search

Navigation